A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis Dependent
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Daprodustat (Primary) ; Acetylcholine; Darbepoetin alfa; Sodium nitroprusside
- Indications Anaemia
- Focus Pharmacodynamics
- Acronyms FBF-CKD
- Sponsors GlaxoSmithKline
- 09 Mar 2018 Last checked against ClinicalTrials.gov record.
- 05 Mar 2018 Planned End Date changed from 6 Mar 2019 to 5 Apr 2019.
- 05 Mar 2018 Planned primary completion date changed from 6 Mar 2019 to 5 Apr 2019.